Abstract:Background and aim: COVID-19, the infectious disease caused by SARS-CoV-2 virus that has been causing a severe pandemic worldwide for more than 2 years, is characterized by a high heterogeneity of clinical presentations and evolution and, particularly, by a varying severity of respiratory involvement. This study aimed to analyze the diversity and taxonomic composition of the gut microbiota at hospital admission, in order to evaluate its association with COVID-19 outcome. In particular, the association between gut microbiota and a combination of several clinical covariates was analyzed in order to characterize the bacterial signature associate to mild or severe symptoms during the SARS-CoV-2 infection. Materials and methods: V3–V4 hypervariable region of 16S rRNA gene sequencing of 97 rectal swabs from a retrospective cohort of COVID-19 hospitalized patients was employed to study the gut microbiota composition. Patients were divided in two groups according to their outcome considering the respiratory supports they needed during hospital stay: (i) group "mild," including 47 patients with a good prognosis and (ii) group "severe," including 50 patients who experienced a more severe disease due to severe respiratory distress that required non-invasive or invasive ventilation. Identification of the clusters of bacterial population between patients with mild or severe outcome was assessed by PEnalized LOgistic Regression Analysis (PELORA). Results: Although no changes for Chao1 and Shannon index were observed between the two groups a significant greater proportion of Campylobacterota and Actinobacteriota at phylum level was found in patients affected by SARS-CoV-2 infection who developed a more severe disease characterized by respiratory distress requiring invasive or non-invasive ventilation. Clusters have been identified with a useful early potential prognostic marker of the disease evolution. Discussion: Microorganisms residing within the gut of the patients at hospital admission, were able to significantly discriminate the clinical evolution of COVID-19 patients, in particular who will develop mild or severe respiratory involvement. Our data show that patients affected by SARS-CoV-2 with mild or severe symptoms display different gut microbiota profiles which can be exploited as potential prognostic biomarkers paving also the way to new integrative therapeutic approaches.

Guild-Level Microbiome Signature Associated with COVID-19 Severity and Prognosis

Gut Microbiota Improves Prognostic Prediction in Critically Ill COVID-19 Patients Alongside Immunological and Hematological Indicators

Dynamics of the Upper Respiratory Tract Microbiota and Its Association with Fatality in COVID-19 Patients

Integrated Analysis of Gut Microbiome and Host Immune Responses in COVID-19

Gut microbiota composition is associated with disease severity and host immune responses in COVID-19

Microbiome Profiling Using Shotgun Metagenomic Sequencing Identified Unique Microorganisms in COVID-19 Patients With Altered Gut Microbiota

Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19

Gut Mycobiota Alterations in Patients with COVID-19 and H1N1 Infections and Their Associations with Clinical Features

Gut mycobiota alterations in patients with COVID-19 and H1N1 and associations with immune and gastrointestinal symptoms

Metagenomic assessment of gut microbial communities and risk of severe COVID-19

Large-scale genetic correlation studies explore the causal relationship and potential mechanism between gut microbiota and COVID-19-associated risks

Gut Microbiota Imbalance in Colorectal Cancer Patients, the Risk Factor of COVID-19 Mortality

Association of Gut Microbiota with COVID-19 Susceptibility and Severity: A Two-Sample Mendelian Randomization Study.

Gut microbiota, inflammation, and molecular signatures of host response to infection

Causal effects of the gut microbiome on COVID-19 susceptibility and severity: a two-sample Mendelian randomization study

Guild-based analysis for understanding gut microbiome in human health and diseases

Fecal multi-omics analysis reveals diverse molecular alterations of gut ecosystem in COVID-19 patients

Two Competing Guilds As a Core Microbiome Signature for Chronic Diseases

Potential Associations Between Microbiome and COVID-19

Gut microbiome alterations and gut barrier dysfunction are associated with host immune homeostasis in COVID-19 patients

Gut microbiota composition in COVID-19 hospitalized patients with mild or severe symptoms